Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Joanna Popov"'
Autor:
Austin Dalrymple, Paul Tuttle, Lance Feller, Olga Zhukov, Robert Lagier, Joanna Popov, Stanley Naides, Terry Moore
Publikováno v:
Pediatric Reports, Vol 13, Iss 1, Pp 65-71 (2021)
The 14-3-3η (eta) protein was evaluated as a biomarker in a cohort of patients with juvenile idiopathic arthritis (JIA), as well as disease- and healthy-controls, to determine its potential clinical utility. In this case-control study, levels of 14-
Externí odkaz:
https://doaj.org/article/7e28316fff9e4303b835c18b26c8b4fb
Autor:
Joanna Popov, Robert J. Lagier, Austin M. Dalrymple, Lance Feller, Olga Zhukov, Stanley J. Naides, Terry L. Moore, Paul V. Tuttle
Publikováno v:
Pediatric Reports
Volume 13
Issue 1
Pages 8-71
Pediatric Reports, Vol 13, Iss 8, Pp 65-71 (2021)
Volume 13
Issue 1
Pages 8-71
Pediatric Reports, Vol 13, Iss 8, Pp 65-71 (2021)
The 14-3-3&eta
(eta) protein was evaluated as a biomarker in a cohort of patients with juvenile idiopathic arthritis (JIA), as well as disease- and healthy-controls, to determine its potential clinical utility. In this case-control study, levels
(eta) protein was evaluated as a biomarker in a cohort of patients with juvenile idiopathic arthritis (JIA), as well as disease- and healthy-controls, to determine its potential clinical utility. In this case-control study, levels
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::daba30fdf89e5648b24b32c064683a21
http://europepmc.org/articles/PMC7844622
http://europepmc.org/articles/PMC7844622
Publikováno v:
Haemophilia. 18:777-781
The evaluation of a prolonged aPTT often includes Lupus Anticoagulant, Antiphospholipid Antibodies, and Factor VIII (FVIII) inhibitors. We have noticed that patient samples positive for lupus antibody (LA) are frequently also positive for FVIII IgG a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1918122746b892b3578b977b6900efb5
https://doi.org/10.1111/j.1365-2516.2012.02781.x
https://doi.org/10.1111/j.1365-2516.2012.02781.x
Autor:
Mervyn A. Sahud, C. Vause, R. Ramos, Olga Zhukov, Joanna Popov, Susan Ruden, Jeffrey S. Dlott, Anthony Sferruzza
Publikováno v:
Haemophilia : the official journal of the World Federation of Hemophilia. 15(3)
Laboratory diagnosis of von Willebrand disease type 2N (VWD2N) is based on costly mutation analysis or in vitro measurement of the ability of plasma von Willebrand factor (VWF) to bind exogenous factor VIII (FVIII); however, the VWF-FVIII binding act
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e41b57ef720b8a66e12a0b83a5c4758b
https://pubmed.ncbi.nlm.nih.gov/19298374
https://pubmed.ncbi.nlm.nih.gov/19298374
Autor:
C.M. Rowland, Kaleb Michaud, Olga Zhukov, Joanna Popov, Stanley J. Naides, R.W. Abolhosn, J.G. Rivera
Publikováno v:
Annals of the Rheumatic Diseases. 74:255.1-255
Background Tissue distribution of the chaperonin 14-3-3η (eta) is limited to synovial tissue and brain. Synovium releases proinflammatory 14-3-3η into synovial fluid and serum in rheumatoid arthritis (RA) patients and, to a lesser extent, erosive p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a2b731c88e26cb6261a9a40ca5f01ff4
https://doi.org/10.1136/annrheumdis-2015-eular.6498
https://doi.org/10.1136/annrheumdis-2015-eular.6498
Publikováno v:
Clinical chemistry. 52(10)
Background: Von Willebrand disease (VWD) diagnosis and classification usually require a combination of nonspecific and VW-factor (VWF)-specific assays. We evaluated the analytical performance of a commercially available collagen-binding assay (CBA) a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cd67328edde77a66268d32d6d545b0f8
https://pubmed.ncbi.nlm.nih.gov/16887898
https://pubmed.ncbi.nlm.nih.gov/16887898
Autor:
Anthony Marotta, Stanley J. Naides, Joanna Popov, Y. Gui, Olga Zhukov, Walter P. Maksymowych, K. Lam, R.W. Abolhosn
Publikováno v:
Annals of the Rheumatic Diseases. 73:1111.2-1111
Background The soluble biomarker sub-committee of OMERACT has published validation criteria for biomarkers reflecting structural damage end-points that focus on assay performance characteristics to address the impact of potential confounders. The 14-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::320276abe96792edccb38fb767c27d78
https://doi.org/10.1136/annrheumdis-2014-eular.3032
https://doi.org/10.1136/annrheumdis-2014-eular.3032
Autor:
M.-L. V. Zambales, T. T. Pizarro, F. Zarabpouri, V. O. Miralles, Stanley J. Naides, Joanna Popov
Publikováno v:
Annals of the Rheumatic Diseases. 72:A279.2-A279
Background ANA screening is a gateway test in the laboratory evaluation of autoimmunity. High-throughput enzyme immunoassays (EIAs) have largely replaced traditional IFA methods but have raised concerns about the limited number of antigen specificiti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2253ed37315ea3ea62ede10b0b8d435a
https://doi.org/10.1136/annrheumdis-2013-eular.865
https://doi.org/10.1136/annrheumdis-2013-eular.865
Publikováno v:
Annals of the Rheumatic Diseases. 72:A386.2-A386
Background The 14-3-3 proteins are ubiquitously-expressed intracellular chaperonins. Expression of the η (eta) isoform is restricted to synovial and CNS tissues.1 Extracellular 14-3-3η induces proinflammatory MAPK and NFkB cascades in THP-1 cells i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::658fc52e89a096f3db7270415eca8d8d
https://doi.org/10.1136/annrheumdis-2013-eular.1181
https://doi.org/10.1136/annrheumdis-2013-eular.1181
Publikováno v:
Blood. 106:4046-4046
Background: The thrombin generation assay (TGA) allows evaluation of the overall coagulation capacity of patients. The original TGA protocol, which required sub-sampling and plasma defibrination procedures, was labor intensive and suffered from techn
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::809d1bf71088e3720d8d69ef9e358d53
https://doi.org/10.1182/blood.v106.11.4046.4046
https://doi.org/10.1182/blood.v106.11.4046.4046